IV, Oral Antibiotics Compared for Complicated Pneumonia

Share this content:
IV, Oral Antibiotics Compared for Complicated Pneumonia
IV, Oral Antibiotics Compared for Complicated Pneumonia

THURSDAY, Nov. 17, 2016 (HealthDay News) -- For children with complicated pneumonia, peripherally inserted central venous catheter (PICC) and oral antibiotic administration post-discharge have similar rates of treatment failure, according to a study published online Nov. 17 in Pediatrics.

Samir S. Shah, M.D., from Cincinnati Children's Hospital Medical Center, and colleagues conducted a multicenter retrospective cohort study involving children aged ≥2 months and <18 years discharged with complicated pneumonia between 2009 and 2012. Route of post-discharge antibiotic administration was the main exposure and classified as PICC or oral. The primary outcome assessed was treatment failure.

The researchers found that 13.2 percent of the 2,123 children received antibiotics via PICC. The treatment failure rates were 3.2 and 2.6 among PICC and oral antibiotic recipients, respectively, and did not differ significantly between the groups in across-hospital-matched analysis (matched odds ratio, 1.26; 95 percent confidence interval, 0.54 to 2.94). In 7.1 percent of cases there were PICC complications. In 0.6 percent of children there were adverse drug reactions; the odds of adverse drug reactions were greater in PICC antibiotic recipients in across-hospital-matched analysis (matched odds ratio, 19.1; 95 percent confidence interval, 4.2 to 87.3). PICC antibiotic recipients had higher odds of the composite outcome of all related revisits, which was partially attributed to the high rate of PICC complications and differences in adverse drug reactions (matched odds ratio, 4.71; 95 percent confidence interval, 2.97 to 7.46).

"Children with complicated pneumonia should preferentially receive oral antibiotics at discharge when effective oral options are available," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease


Sign up for myCME e-newsletters


More in Home

Onabotulinum Toxin-A Can Safely Improve Sleep Bruxism

Onabotulinum Toxin-A Can Safely Improve Sleep Bruxism

Improved clinical global impression and change in visual analog scale, pain at 4 to 8 weeks post therapy

Professionals Disagree About Asking Patients About Sexuality

Professionals Disagree About Asking Patients About Sexuality

Article offers opposing views about recommendation in England to ask patients about sexual orientation

Value of Doxylamine-Pyridoxine Questioned in Early Pregnancy

Value of Doxylamine-Pyridoxine Questioned in Early Pregnancy

Greater improvement in symptom scores versus placebo, but clinical relevance unclear

is free, fast, and customized just for you!

Already a member?

Sign In Now »